Dr. Lorinda Susan Chung, MD

Dr. Chung practices at Stanford Hospital at 300 Pasteur Drive in Stanford, California, part of Stanford University.

Dr. Chung's NPI, 1427026442, was assigned on March 8, 2006. Dr. Chung graduated from Ohio State College of Medicine in 2000. Dr. Chung holds California license A76014.

Dr. Chung's primary practice is Stanford Hospital at 300 Pasteur Drive, at 300 Pasteur Drive, Stanford, CA 94305 in Santa Clara County. The practice phone is (650) 723-4000.

Dr. Chung's primary practice is Stanford Hospital at 300 Pasteur Drive in Stanford, California, part of Stanford University. The medical group on file is Stanford Health Care. Dmand AI also links Dr. Chung to 1 more hospital, 2 group practices and clinics and 1 medical group, each named with a free account. Dr. Chung's employer is on file too: a hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Chung practices, 4 sites in all. Vendor and product names are available with a free account.

Rheumatology is Dr. Chung's primary specialty in the NPI Registry, under taxonomy code 207RR0500X. Dr. Chung is board certified in rheumatology by the American Board of Internal Medicine. Dmand AI has Dr. Chung's licenses on file in 2 states: California and Hawaii.

Dmand AI lists gout, lupus and muscle pain, fibromyalgia, and limb pain among the conditions Dr. Chung treats.

CMS data shows 262 Medicare services from Dr. Chung across 6 procedure codes in 2024, for 103 Medicare patients. Medicare paid $20,577 for them.

CMS counts 103 Medicare patients who saw Dr. Chung in 2024. The largest group is 65 to 74, with 47 patients. 64% of them have high cholesterol, and 58% have arthritis. 27% are also on Medicaid. Their average risk score is 1.95, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Chung's median patient age at 58, with 80% women.

In 2024, Dr. Chung wrote 204 Medicare Part D claims for 42 patients. 88% of them were for generic drugs. CMS names the drug for 78 of them, across 4 drugs with 11 or more claims each, at $3,403 in total drug cost. In 2023, CMS named 170 claims across 8 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 89 out of 100 for Dr. Chung for performance year 2024, reported as part of a group. Dr. Chung accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Chung as offering telehealth.

Removal of skin lesions: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 201 papers to Dr. Chung, published from 2007 to 2025. 2020 was the busiest year, with 21. The most frequent topics are Scleroderma, Systemic, Dermatomyositis and Hypertension, Pulmonary. Dr. Chung has published most often in Arthritis Care Res (Hoboken). Dr. Chung's most frequent co-authors are David Franklin Fiorentino, MD, Dinesh Khanna, MD and Virginia Steen.

Dmand AI links Dr. Chung to 9 clinical trials, 7 of them phase 2 studies. 1 is still active or recruiting. Conditions studied include Scleroderma, Systemic, Scleroderma, Diffuse and Calcinosis. Stanford University sponsors the most, 2.

CMS Open Payments shows 108 general payments to Dr. Chung from 11 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 86% of the total. Boehringer Ingelheim Pharmaceuticals, Inc. paid the most, $21,779. It also lists 1 research payment totaling $103 in 2016.

Dmand AI lists 2 awards for Dr. Chung, most recently CMS Stage 1 EHR in 2013.

Dr. Chung graduated from Ohio State College of Medicine in 2000. Dr. Chung is a member of ACR.

Dr. Chung is in network with 10 carriers, including Aetna, Blue Cross Blue Shield of Michigan and Elevance. Medicare plans come from the most carriers, 7. Check the plan with the practice before a visit.